1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 30 MARCH 2015

CNS Drug News 30 MARCH 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Dementia Research To See Increased Investment
Industry Brief - Opicapone Significantly Improves Off Time In Fluctuating PD Patients As Add-On To Levodopa
Industry Brief - AbbVie/C2N Enter Worldwide Licence Agreement For AD Therapy
Industry Brief - Novartis Buys Out CAD106 Licence Agreement For CHF4mn
Industry Brief - GliaCure Receives Grant For Phase Ib AD Trial
Industry Brief - EMA Validates Zinbryta MAA For MS
Industry Brief - Masitinib Receives FDA ODD For ALS
Industry Brief - FDA Grants Treeway's TW001 ODD For ALS
Industry Brief - Mesoblast Granted Japanese Patent Covering MPCs For Cardiovascular Indications
Industry Brief - CERC-301 Misses Primary Endpoint In Phase II Study For MDD
Industry Brief - Otsuka Granted Approval In Japan For New Formulation Of Abilify
Industry Brief - Pre-Filled Dual Chamber Syringe For Abilify Maintena Receives Positive CHMP Opinion
Industry Brief - Vyvanse 10mg Available In US
Industry Brief - Milestone Triggered By Advancement Of Shionogi's Abuse-Deterrent Hydrocodone
Industry Brief - Teva's TEV-48125 Meets Primary/Secondary Endpoints In Episodic Migraine Study
Industry Brief - Lyrica Phase IV Study In Adolescents With Fibromyalgia Misses Primary Endpoint
Industry Brief - PAION Initiates US Phase III Trial Of Remimazolam
Industry Brief - Aurobindo Gains Lacosamide Tentative Approval
Industry Brief - GW Initiates First Phase III Pivotal Trial For Epidiolex In Dravet Syndrome
Industry Brief - Marinus' Ganaxolone Receives FDA ODD In PCDH19 Female Epilepsy
Industry Trend Analysis - Mysimba Will Have Fewer Competitors But Sales Dampened By Safety Concerns
Industry Brief - Helsinn Receives Positive CHMP Opinion On Akynzeo For CINV Prevention
Industry Brief - Confluence/AOP Orphan To Co-Develop Fragile X Syndrome Drug
Industry Brief - Consilient Launches Pregabalin Capsules In UK
Industry Brief - Macrophage Therapeutics To Expand Efforts Into CNS Diseases
Industry Trend Analysis - Successful Diversification Will Help Newly Named Biogen Sustain Growth
Industry Brief - BioCorRx Reports Reinstatement Of LOU To Acquire Naltrexone Implant Formula

Table Of Contents

CNS Drug News 30 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027

Epiomic Epidemiology Series: Vascular Dementia Forecast in 13 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • January 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Vascular Dementia in 13 Major Markets Vascular Dementia (VaD) is the second most common form of dementia after Alzheimer disease. ...

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

"Global Multi Infarct Dementia Market Research Report 2016" by OBRC, is an extensive study on present state of the Multi Infarct Dementia Market. The global multi-infarct dementia is estimated to reach ...

Alzheimer’s disease (AD) - Epidemiology Forecast To 2023

Alzheimer’s disease (AD) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Alzheimer’s disease (AD) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Alzheimer’s disease (AD) in seven major markets (US, France, Germany, ...

Cns Drug News 19 September 2016

September 2016 $ 1255

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.